SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Current Status of Cost Utility Analyses in Total Joint Arthroplasty: A Systematic Review
16 references·2 citing·34 second hop
Current Status of Cost Utility Analyses in Total Joint Arthroplasty: A Systematic Review (2014)Current Status of Cost Utility Analyses i…Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Updating Cost-Effectiveness —…Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions (2011)Using threshold values for co…Health Care Reform and Cost Control (2010)Health Care Reform and Cost C…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Medicare and Cost-Effectiveness Analysis (2005)Medicare and Cost-Effectivene…COST-UTILITY ANALYSES IN ORTHOPAEDIC SURGERY (2005)COST-UTILITY ANALYSES IN ORTH…Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES (2003)Examining the Value and Quali…Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies (2003)Development and Validation of…Willingness to Pay for a Quality-adjusted Life Year (2000)Willingness to Pay for a Qual…The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine (1996)The role of cost-effectivenes…The Role of Cost-effectiveness Analysis in Health and Medicine (1996)The Role of Cost-effectivenes…Recommendations of the Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations of the Panel …Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine (1996)Recommendations for reporting…Recommendations for Reporting Cost-effectiveness Analyses (1996)Recommendations for Reporting…Panel on cost-effectiveness in health and medicine. (1996)Panel on cost-effectiveness i…Determining Cost-Effectiveness of Total Hip and Knee Arthroplasty Using the Short Form-6D Utility Measure (2016)Determining Cost-Effectivenes…Updating Cost Effectiveness Analyses in Orthopedic Surgery: Resilience of the $50,000 per QALY Threshold (2015)Updating Cost Effectiveness A…Contingent Valuation: Is Some Number Better than No Number? (1994)Cost-Effectiveness in Health and Medicine (1996)Cost-of-illness studies: concepts, scopes, and methods (2014)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Social Security Bulletin (2018)Methods for the Economic Evaluation of Health Care Programmes (2005)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Use of Cost-Effectiveness Analysis in Health-Care Resource Allocation Decision-Making: How Are Cost-Effectiveness Thresholds Expected to Emerge? (2004)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. (1986)Searching for the structure of coping: A review and critique of category systems for classifying ways of coping. (2003)Systematic review of economic analyses of health care-associated infections (2005)Using thematic analysis in psychology (2006)Lifetime Economic Burden of Intimate Partner Violence Among U.S. Adults (2018)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review (2018)Economics and mental health: the current scenario (2020)Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report (2005)International survey on willingness‐to‐pay (WTP) for one additional QALY gained: what is the threshold of cost effectiveness? (2009)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)HALYs and QALYs and DALYs, Oh My: Similarities and Differences in Summary Measures of Population Health (2002)
this work references cited by second hop

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 1996Recommendations of the Panel on Cost-Effectiveness in Health and Medicine2,455 cited
  • 2014Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold2,247 cited
  • 1996The Role of Cost-effectiveness Analysis in Health and Medicine1,168 cited
  • 1996Recommendations for Reporting Cost-effectiveness Analyses1,146 cited
  • 1996Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine1,037 cited
  • 1996The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine967 cited
  • 2000Willingness to Pay for a Quality-adjusted Life Year849 cited
  • 1996Panel on cost-effectiveness in health and medicine.492 cited
  • 2003Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES365 cited
  • 2003Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies311 cited
  • 2010Health Care Reform and Cost Control249 cited
  • 2005Medicare and Cost-Effectiveness Analysis225 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2005COST-UTILITY ANALYSES IN ORTHOPAEDIC SURGERY131 cited
  • 2011Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions129 cited
  • Cited by

    • 2015Updating Cost Effectiveness Analyses in Orthopedic Surgery: Resilience of the $50,000 per QALY Threshold58 cited
    • 2016Determining Cost-Effectiveness of Total Hip and Knee Arthroplasty Using the Short Form-6D Utility Measure56 cited